Search

Your search keyword '"del Campo, R."' showing total 82 results
Start Over Author "del Campo, R." Publisher elsevier bv
82 results on '"del Campo, R."'

14. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

Author

López-Causapé C, de Dios-Caballero J, Cobo M, Asensio Ó, Del Campo R, Solé A, Cortell I, Asensio O, García G, Martínez MT, Cols M, Salcedo A, Vázquez C, Baranda F, Girón R, Quintana E, Delgado I, de Miguel MÁ, García M, Oliva C, Prados MC, Barrio MI, Pastor MD, Olveira C, de Gracia J, Álvarez A, Escribano A, Castillo S, Figuerola J, Togores B, Oliver A, López C, de Dios Caballero J, Tato M, Máiz L, Suárez L, and Cantón R

Subjects
Virulence, Antibiotic resistance, Array tube, Multi-locus sequence typing (MLST), Pseudomonas aeruginosa, Cystic fibrosis
Abstract

The first Spanish multi-centre study on the microbiology of cystic fibrosis (CF) was conducted from 2013 to 2014. The study involved 24 CF units from 17 hospitals, and recruited 341 patients. The aim of this study was to characterise Pseudomonas aeruginosa isolates, 79 of which were recovered from 75 (22%) patients. The study determined the population structure, antibiotic susceptibility profile and genetic background of the strains. Fifty-five percent of the isolates were multi-drug-resistant, and 16% were extensively-drug-resistant. Defective mutS and mutL genes were observed in mutator isolates (15.2%). Considerable genetic diversity was observed by pulsed-field gel electrophoresis (70 patterns) and multi-locus sequence typing (72 sequence types). International epidemic clones were not detected. Fifty-one new and 14 previously described array tube (AT) genotypes were detected by AT technology. This study found a genetically unrelated and highly diverse CF P. aeruginosa population in Spain, not represented by the epidemic clones widely distributed across Europe, with multiple combinations of virulence factors and high antimicrobial resistance rates (except for colistin).

Published
2017

15. Multiple Myeloma (MM) in First Relapse Patients: Role of the Second Autologous Stem-Cell Trasplant (ASCT): Experience of Two Centers

Author

Muntañola Ana, Teresa Villalobos, Amer N, Vélez Patricia, Canet Marta, Baragay J, Del Campo R, Mahmud Mohamed, Martí Josep María, Borrás J, and Vall-lloveras Ferran

Subjects
Oncology, Cancer Research, First relapse, medicine.medical_specialty, business.industry, Internal medicine, medicine, Hematology, Stem cell, medicine.disease, business, Multiple myeloma
Published
2019

16. Systematic review of kidney transplantation functional predictors

Author

Miret-Alomar, E., primary, Trilla-Herrera, E., additional, Lorente-Garcia, D., additional, Regis-Placido, L., additional, López del Campo, R., additional, Cuadras-Solé, M., additional, Pont-Castellana, T., additional, Moreso-Mateos, F., additional, Serón-Micas, D., additional, and Morote-Robles, J., additional

Published
2018
Full Text
View/download PDF

18. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

Author

de Dios Caballero, J., del Campo, R., Royuela, A., Solé, A., Máiz, L., Olveira, C., Quintana-Gallego, E., de Gracia, J., Cobo, M., de la Pedrosa, E.G.G., Oliver, A., Cantón, R., Cortell, I., Asensio, O., García, G., Martínez, M.T., Cols M, Salcedo, A., Vázquez, C., Baranda, F., Girón, R., Quintana, E., Delgado, I., de Miguel, M.Á., García, Oliva, C., Prados, M.C., Barrio, M.I., Pastor, M.D., Álvarez, A., Escribano, A., Castillo, S., Figuerola, J., Togores, B., López, C., Tato, M., and Suárez, L.

Published
2016

19. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism

Author

RIERA MESTRE, A., Jiménez, D., Muriel, A., Lobo, J. L., Moores, L., Yusen, R. D., Casado, I., Nauffal, D., Oribe, M., Monreal, M., Monreal, M, Decousus, H, Prandoni, Paolo, Brenner, B, Barba, R, Di Micco, P, Bertoletti, L, Papadakis, M, Bounameaux, H, Bosevski, M, Arcelus, Ji, Arcos, P, Barrón, M, Blanco, A, Bosco, J, Campano, F, Casado, I, Casas, Jm, Cisneros, E, Chaves, E, Conget, F, del Campo, R, del Toro, J, Falgá, C, Fernández Capitán, C, Ferreiro, M, Font, C, Gabriel, F, Gallego, P, García Bragado, F, Guil, M, Gutiérrez, J, Hernández, L, Hernández Huerta, D, Jaras, M, Jiménez Castro, D, Jiménez, S, Jiménez Gil, M, Lecumberri, R, Lobo, Jl, López Jiménez, L, Lorenzo, A, Luque, Jm, Madridano, O, Maestre, A, Marchena, Pj, Martín Villasclaras JJ, Mascareño, Mc, Morales, M, Nauffal, Md, Nieto, Ja, Núñez, Mj, Ogea, Jl, Ogea, M, Otero, R, Pedrajas, Jm, Rabuñal, R, Riera Mestre, A, Rodríguez Dávila MA, Roldán, V, Román, M, Román, P, Rosa, V, Rubio, S, Ruiz, Md, Ruíz, J, Ruiz Gamietea, A, Sahuquillo, Jc, Samperiz, A, Sánchez, R, Sánchez Muñoz Torrero JF, Soler, S, Soto, M, Tiberio, G, Tolodí, Ja, Tolosa, C, Torres, Mi, Trujillo, J, Uresandi, F, Valdés, M, Valdés, V, Valdés, R, Vidal, G, Villalta, J, Zorrilla, V, Bura Riviere, A, Debourdeau, P, Durant, C, Farge Bancel, D, Mahe, I, Rivron Guillot, K, Zeltser, D, Barillari, A, Barillari, G, Ciammaichella, M, Dalla Valle, F, Duce, R, Farneti, L, Maida, R, Pasca, S, Piovella, C, Poggio, R, Prandoni, P, Quintavalla, R, Schenone, A, Tiraferri, E, Tonello, D, Visonà, A, and Bounameaux, H.

Subjects
Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Blood Pressure, Lower risk, Risk Assessment, Fibrinolytic Agents, Predictive Value of Tests, Risk Factors, Internal medicine, Odds Ratio, medicine, Humans, Thrombolytic Therapy, Registries, Israel, Propensity Score, Intensive care medicine, Aged, Retrospective Studies, Aged, 80 and over, Chi-Square Distribution, business.industry, Retrospective cohort study, Hematology, Thrombolysis, Odds ratio, Middle Aged, medicine.disease, Pulmonary embolism, Europe, Logistic Models, Treatment Outcome, Predictive value of tests, Acute Disease, Propensity score matching, Cardiology, Female, Pulmonary Embolism, business, Chi-squared distribution
Abstract

To cite this article: Riera-Mestre A, Jimenez D, Muriel A, Lobo JL, Moores L, Yusen RD, Casado I, Nauffal D, Oribe M, Monreal M, for the RIETE investigators. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism. J Thromb Haemost 2012; 10: 751-9. Summary. Background: While the primary therapy for most patients with a pulmonary embolism (PE) consists of antico- agulation, the efficacy of thrombolysis relative to standard therapy remains unclear. Methods: In this retrospective cohort study of 15 944 patients with an objectively confirmed symp- tomatic acute PE, identified from the multicenter, international, prospective, Registro Informatizado de la Enfermedad TromboEmbolica (RIETE registry), we aimed to assess the association between thrombolytic therapy and all-cause mor- tality during the first 3 months after the diagnosis of a PE. After creating two subgroups, stratified by systolic blood pressure (SBP) (< 100 mm Hg vs. other), we used propensity score- matching for a comparison of patients who received thrombol- ysis to those who did not in each subgroup. Results: Patients who received thrombolysis were younger, had fewer comorbid diseases and more signs of clinical severity compared with those who did not receive it. In the subgroup with systolic hypoten- sion, analysis of propensity score-matched pairs (n = 94 pairs) showed a non-statistically significant but clinically relevant lower risk of death for thrombolysis compared with no thrombolysis (odds ratio (OR) 0.72; 95% confidence interval (CI), 0.36-1.46; P = 0.37). In the normotensive subgroup, analysis of propensity score-matched pairs (n = 217 pairs) showed a statistically significant and clinically meaningful increased risk of death for thrombolysis compared with no thrombolysis (OR 2.32; 95% CI, 1.15-4.68; P = 0.018). When we imputed data for missing values for echocardiography and troponin tests in the group of normotensive patients, we no longer detected the increased risk of death associated with thrombolytic therapy. Conclusions: In normotensive patients with acute symptomatic PE, thrombolytic therapy is associated with a higher risk of death than no thrombolytic therapy. In hemodynamically unstable patients, thrombolytic therapy is possibly associated with a lower risk of death than no thrombolytic therapy. However, study design limitations do not imply a causal relationship between thrombolytics and outcome.

Published
2012

20. Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry

Author

Javier Trujillo Santos, José Manuel Casa, Ignacio, Casado, Ángel Luis Samperiz, Roberto, Quintavalla, Joan Carles Sahuquillo, Manuel, Monreal, Arcelus, Ji, Barba, R, Barrón, M, Blanco, A, Bosco, J, Casado, I, Casas, Jm, Cisneros, E, Chavez, E, del Campo, R, del Molino, F, del Toro, J, Durán, M, Falgá, C, Fernández Capitán, C, Gabriel, F, Gallego, P, García Bragado, F, Guijarro, R, Guil, M, Gutiérrez, J, Gutiérrez, Mr, Hernández, L, Hernández Toboso, S, Jiménez, D, Jiménez Gil, M, Jordán, S, Lecumberri, R, Lobo, Jl, López Jiménez, L, Lorenzo, A, Luque, Jm, Madridano, O, Maestre, A, Marchena, Pj, Martín Villasclaras JJ, Montes, J, Monreal, M, Morales, M, Nauffal, Md, Nieto, Ja, Núñez, Mj, Ochoa, F, Ogea, Jl, Oribe, M, Otero, R, Pedrajas, Jm, Ponce de León, L, Rabuñal, R, Riera Mestre, A, Rodríguez, Ma, Roldán, V, Román, P, Rosa, V, Rubio, S, Ruiz Gamietea, A, Ruíz Giménez, N, Sahuquillo, Jc, Samperiz, A, Sánchez, R, Muñoz Torrero SJ, Soler, S, Soto, Mj, Tiberio, G, Tolodí, Ja, Tolosa, C, Trujillo, J, Uresandi, F, Valdés, M, Valdés, V, Valdés, R, Vidal, G, Villalta, J, Boccalon, H, Debourdeau, P, Durant, C, Farge Bancel, D, Mahe, I, Rivron Guillot, K, Brenner, B, Barillari, A, Barillari, G, Ciammaichella, M, Di Micco, P, Dalla, Vf, Duce, R, Pasca, S, Piovella, C, Poggio, R, Prandoni, Paolo, Quintavalla, R, Schenone, A, Tiraferri, E, Visonà, A, Bosevski, M, and Bounameaux, H.

Subjects
Adult, medicine.medical_specialty, Hemorrhage, Neoplasms, Internal medicine, Pancreatic cancer, medicine, Carcinoma, Humans, Prospective Studies, Registries, Prospective cohort study, Aged, Aged, 80 and over, Gynecology, Lung, business.industry, Mortality rate, Anticoagulants, Cancer, Venous Thromboembolism, Hematology, Middle Aged, medicine.disease, Pulmonary embolism, Treatment Outcome, medicine.anatomical_structure, Female, Pulmonary Embolism, business, Ovarian cancer
Abstract

The influence of the site of cancer on outcome in cancer women with venous thromboembolism (VTE) is poorly understood. Reliable information on its influence might facilitate better use of prevention strategies. We assessed the 30-day outcome in all women with active cancer in the RIETE Registry, trying to identify if differences exist according to the tumor site. Up to May 2010, 2474 women with cancer and acute VTE had been enrolled. The most common sites were the breast (26%), colon (13%), uterus (9.3%), and haematologic (8.6%) cancers. During the 30-day study period, 329 (13%) patients died. Of them, 71 (2.9%) died of pulmonary embolism (PE), 22 (0.9%) died of bleeding. Fatal PE was more common in women with breast, colorectal, lung or pancreatic cancer (59% of the fatal PEs). Fatal bleeding was more frequent in women with colorectal, haematologic, ovarian cancer or carcinoma of unknown origin (55% of fatal bleedings).

Published
2011

26. Intestinal inflammation worsens epithelial barrier function in rats with cirrhosis and ascites: role of commensal gut flora

Author

Muñoz, L., primary, Borrero, M.-J., additional, Ubeda, M., additional, Paule, L., additional, Lario, M., additional, Díaz, D., additional, Conde, E., additional, Rodríguez-Serrano, M., additional, Sánchez-Díaz, A.-M., additional, del Campo, R., additional, Pastor, Ó., additional, García-Bermejo, L., additional, Álvarez-Mon, M., additional, and Albillos, A., additional

Published
2017
Full Text
View/download PDF

31. The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?

Author

Sánchez-Díaz, A.M., primary, Cuartero, C., additional, Rodríguez, J.D., additional, Lozano, S., additional, Alonso, J.M., additional, Rodríguez-Domínguez, M., additional, Tedim, A.P., additional, del Campo, R., additional, López, J., additional, Cantón, R., additional, and Ruiz-Garbajosa, P., additional

Published
2016
Full Text
View/download PDF

35. Response to “In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: implications of the innate immune response”

Author

López-Collazo, E, primary, Jurado, T, additional, de Dios Caballero, J, additional, Pérez-Vázquez, M, additional, Vindel, A, additional, Hernández-Jiménez, E, additional, Tamames, J, additional, Cubillos-Zapata, C, additional, Manrique, M, additional, Tobes, R, additional, Máiz, L, additional, Cantón, R, additional, Baquero, F, additional, and del Campo, R, additional

Published
2015
Full Text
View/download PDF

36. 211 SPANISH REGISTRY OF ERYTHROPOIETIC STIMULATING AGENTS STUDY: THE LARGEST RETROSPECTIVE STUDY OF ESAS FOR THE TREATMENT OF ANEMIA IN LOWER RISK MDS PATIENTS

Author

Campelo, M. Diez, primary, Lorenzo, J.I., additional, Benlloch, L., additional, Lopez-Pavia, M., additional, Such, E., additional, Bernal, T., additional, Luño, E., additional, Davila, J., additional, Ramos, F., additional, Calabuig, M., additional, Pomares, H., additional, Gonzalez, B., additional, Merchan, B., additional, Barranco, E., additional, Tello, R. Sancho, additional, Callejas, M., additional, Requena, M.J., additional, Jimenez, M.J., additional, Pedreño, M., additional, Vicente, A.I., additional, Medina, A., additional, Campeny, A., additional, Sansa, M. Cortes, additional, Pedro, C., additional, Falantes, J.F., additional, Arilla, M.J., additional, Barez, A., additional, Garcia, R., additional, Arcos, M.J., additional, Gomez, V., additional, Muñoz, C., additional, Cervero, C., additional, Casaño, J., additional, de Paz, R., additional, Amigo, L., additional, Insunza, A., additional, Muñoz, J.A., additional, Cedena, M.T., additional, Gomez, M., additional, Font, P., additional, del Campo, R., additional, Lago, C. Fernandez, additional, Hurtado, J.A. Gonzalez, additional, Latorre, M.D. Linares, additional, Casado, A. Mora, additional, Vahi, M., additional, Sanz, G.F., additional, and Cañizo, M.C., additional

Published
2015
Full Text
View/download PDF

37. In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: implications of the innate immune response

Author

López-Collazo, E., primary, Jurado, T., additional, de Dios Caballero, J., additional, Pérez-Vázquez, M., additional, Vindel, A., additional, Hernández-Jiménez, E., additional, Tamames, J., additional, Cubillos-Zapata, C., additional, Manrique, M., additional, Tobes, R., additional, Máiz, L., additional, Cantón, R., additional, Baquero, F., additional, and del Campo, R., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results